NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Integrum AB Series B (ST: INTEG-B)
INTEG-B Technical Analysis
5
As on 20th Dec 2024 INTEG-B STOCK Price closed @ 19.05 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 39.10 & Strong Sell for SHORT-TERM with Stoploss of 20.39 we also expect STOCK to react on Following IMPORTANT LEVELS. |
INTEG-BSTOCK Price
Open | 18.75 | Change | Price | % |
High | 19.30 | 1 Day | 0.55 | 2.97 |
Low | 17.90 | 1 Week | 0.05 | 0.26 |
Close | 19.05 | 1 Month | -4.45 | -18.94 |
Volume | 146410 | 1 Year | 1.93 | 11.27 |
52 Week High 62.00 | 52 Week Low 16.60 |
ST Sweden Most Active Stocks
FING-B | 0.03 | -25.00% |
WYLD | 0.01 | 0.00% |
SBB-B | 4.10 | 0.49% |
TELIA | 30.18 | -0.26% |
HDW-B | 0.00 | % |
CYB1 | 0.01 | 0.00% |
NIBE-B | 42.17 | 0.19% |
LUNE | 21.97 | 6.65% |
ERIC-B | 89.10 | -0.13% |
ABLI | 0.42 | 0.00% |
ST Sweden Top Gainers Stocks
ST Sweden Top Losers Stocks
INTEG-B Daily Charts |
INTEG-B Intraday Charts |
Whats New @ Bazaartrend |
INTEG-B Free Analysis |
|
INTEG-B Important Levels Intraday
RESISTANCE | 21.75 |
RESISTANCE | 20.88 |
RESISTANCE | 20.35 |
RESISTANCE | 19.81 |
SUPPORT | 18.29 |
SUPPORT | 17.75 |
SUPPORT | 17.22 |
SUPPORT | 16.35 |
INTEG-B Forecast December 2024
4th UP Forecast | 44.1 |
3rd UP Forecast | 36.07 |
2nd UP Forecast | 31.1 |
1st UP Forecast | 26.14 |
1st DOWN Forecast | 11.97 |
2nd DOWN Forecast | 7 |
3rd DOWN Forecast | 2.03 |
4th DOWN Forecast | -6 |
INTEG-B Weekly Forecast
4th UP Forecast | 24.79 |
3rd UP Forecast | 22.95 |
2nd UP Forecast | 21.81 |
1st UP Forecast | 20.67 |
1st DOWN Forecast | 17.43 |
2nd DOWN Forecast | 16.29 |
3rd DOWN Forecast | 15.15 |
4th DOWN Forecast | 13.31 |
INTEG-B Forecast2024
4th UP Forecast | 110.78 |
3rd UP Forecast | 81.36 |
2nd UP Forecast | 63.18 |
1st UP Forecast | 44.99 |
1st DOWN Forecast | -6.89 |
2nd DOWN Forecast | -25.08 |
3rd DOWN Forecast | -43.26 |
4th DOWN Forecast | -72.68 |
Integrum AB Series B ( ST Sweden Symbol : INTEG-B )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
INTEG-B Other Details
Segment | EQ | |
Market Capital | 1419590528.00 | |
Sector | Healthcare | |
Industry | Medical Instruments & Supplies | |
Offical website | > echo $website ; ?> |
INTEG-B Address
INTEG-B Latest News
INTEG-B Business Profile
Integrum AB (publ) researches, develops, and sells various systems for bone-anchored prostheses. The company offers OPRA (Osseointegrated Prostheses for the Rehabilitation of Amputees) implant system, a bone-anchored prostheses system based on osseointegration, where the prostheses are directly attached to the bone, avoiding the use of socket. The OPRA implant system provides protection to the patient by avoiding bone fractures from accidental loads. The company also offers Neuromotus, a technology that is used for therapy to reduce phantom limb pain after an amputation. The company was founded in 1962 and is based in Mölndal, Sweden. Address: Krokslätts Fabriker 50, Mölndal, Sweden, 431 37
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service